Home > Healthcare > Medical Devices > Therapeutic Devices > Neurovascular Devices Market

Neurovascular Devices Market Trends

Report ID: GMI794
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Neurovascular Devices market trends

Disease management in the case of intracranial aneurysms, arteriovenous malformation (AVMs), and strokes is a complex and challenging procedure since no single effective therapy is available for the same, generating a need for more innovative and effective therapies. The major reasons identified for ineffective treatments include complications of surgical therapies such as cerebral artery bypass and aneurysm clipping. Thus, the escalating need for designing more effective and low-cost treatments may hamper the market dynamics.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for neurovascular devices was valued at USD 3.9 billion in 2022 and is poised to exhibit a 6.5% CAGR from 2023 to 2032 due to the surging prevalence of ischemic strokes and brain aneurysm across North America.

The neurovascular devices market from the flow diverters segment is estimated to witness a 7.5% CAGR through 2032, attributed to an increased cognizance of distinctive treatment options for intracranial aneurysm.

The ischemic stroke segment amassed over 40% of the global market share in 2022, given the growing prevalence of ischemic strokes and the rising popularity of minimally invasive procedures.

Notable firms in the neurovascular devices industry include Asahi Intecc Co. Ltd., Integer Holdings Corporation, Johnson & Johnson Services, Kaneka Medix Corp. Medtronic, MicroPort Scientific Corporation, Merit Medical System, Penumbra, Inc., Stryker, and Terumo Corporation.